The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,806.00
Bid: 1,805.50
Ask: 1,806.00
Change: -4.00 (-0.22%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,814.50
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citi Raises Smiths Group To Buy From Neutral

Wed, 21st Oct 2015 08:38

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
CITIGROUP RAISES SMITHS GROUP TO 'BUY' ('NEUTRAL') - TARGET 1,200 (1,050) PENCE
----------
DEUTSCHE BANK RAISES RANDGOLD TO 'BUY' ('HOLD') - TARGET 5,050 (4,640) PENCE
----------
S&P CAPITAL IQ CUTS BHP BILLITON PRICE TARGET TO 1,000 (1,100) PENCE - 'HOLD'
----------
TRADERS: JEFFERIES INITIATES SSE WITH 'HOLD' - TARGET 1,600 PENCE
----------
S&P CAPITAL IQ RAISES INTERCONTINENTAL HOTELS TO BUY ('HOLD') - TARGET 2,800 PENCE
----------
NUMIS CUTS PEARSON PRICE TARGET TO 1,040 (1,110) PENCE - 'REDUCE'
----------
BERNSTEIN CUTS GLAXOSMITHKLINE PRICE TARGET TO 1304 (1401)P - 'MARKET-PERFORM'
----------
BERNSTEIN CUTS ASTRAZENECA PRICE TARGET TO 4346 (4993) PENCE - 'MARKET-PERFORM'
----------
BARCLAYS CUTS WHITBREAD PRICE TARGET TO 5,800 (6,000) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS VODAFONE PRICE TARGET TO 240 (245) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
NUMIS RAISES FIDESSA GROUP TO 'BUY' ('HOLD') - TARGET 2,355 PENCE
----------
JEFFERIES RAISES N BROWN PRICE TARGET TO 430 (406) PENCE - 'BUY'
----------
N+1 Singer Ups N Brown Group Price Target To 410p From 355p, Keeps Buy
----------
JPMORGAN CUTS STAGECOACH PRICE TARGET TO 374 (378) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
PANMURE RAISES GVC HOLDINGS PRICE TARGET TO 484 (552) PENCE - 'BUY'
----------
WH Ireland Cuts 4Imprint To Outperform From Buy, Ups Price Target To 1,415p From 1,300p
----------
Liberum Ups ASOS Price Target To 3,700p From 3,300p, Keeps Buy
----------
SOCGEN RAISES ASOS PRICE TARGET TO 5,050 (4,960) PENCE - 'BUY'
----------
Investec Lifts ASOS to Hold from Sell, Ups Price Target To 3,400p From 3,000p
----------
UBS CUTS GENEL ENERGY TO 'NEUTRAL' ('BUY') - TARGET 400 (500) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.